Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 16;49(4):453-60.
doi: 10.1016/j.ejps.2013.05.014. Epub 2013 May 24.

Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects

Affiliations

Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects

Satomi Onoue et al. Eur J Pharm Sci. .

Abstract

The present study aimed to develop an amorphous solid dispersion (SD) of nobiletin (NOB), a citrus polymethoxylated flavone, with the aim of improving its biopharmaceutical and hepatoprotective properties. SD formulation of NOB (NOB/SD) was prepared by wet-milling and subsequent freeze drying, and its stability and dissolution properties were characterized. The hepatoprotective effects and pharmacokinetic behavior of orally dosed NOB/SD were evaluated in rats. During the storage of NOB/SD for 4 weeks under accelerated conditions, there were no significant transitions in the appearance, particle size, and amorphousity of wet-milled NOB. In comparison with crystalline NOB, the NOB/SD exhibited significant improvement in the dissolution with a 10-fold higher dissolution rate. In a rat model of acute liver injury, repeated treatment with NOB/SD (2 mg NOB/kg) every 4 h led to marked attenuation of hepatic damage as evidenced by decreased ALT and AST, surrogate biomarkers for hepatic injury; however, crystalline NOB was found to be less effective. After oral administration of NOB/SD (2 mg NOB/kg) in rats, compared with crystalline NOB, improved pharmacokinetic behavior was observed with increases of bioavailability and hepatic delivery by ca. 7- and 6-fold, respectively, possibly leading to better hepatoprotection. Given the improved physicochemical and biopharmaceutical properties, the SD formulation strategy might be efficacious for enhancing the therapeutic potential of NOB.

Keywords: ALT; ANOVA; AST; CCl(4); CYP; Ceq; DLS; DSC; Dissolution; H&E; HPC; Hepatoprotection; NAD; NOB; Nobiletin; Oral absorption; PBS; PLM; PM; PXRD; RH; SD; SEM; SIR; Solid dispersion; UPLC/ESI-MS; alanine aminotransferase; analysis of variance; aspartate aminotransferase; carbon tetrachloride; cytochrome P450; differential scanning calorimetry; dynamic light scattering; equilibrium solubility; hematoxylin and eosin; hydroxypropyl cellulose; nicotinamide adenine dinucleotide; nobiletin; phosphate-buffered saline; physical mixture; polarized light microscopy; powder X-ray diffraction; relative humidity; scanning electron microscopy; selected ion recording; solid dispersion; ultra-performance liquid chromatography equipped with electrospray ionization mass spectrometry.

PubMed Disclaimer

Publication types

MeSH terms